The research advances in small molecules related with delaying aging

Progress in Biochemistry and Biophysics

Volumn 37, Issue 9, 2010, Pages 932-938

  Gao, Ling Yun ^a   Li, Guo Dong ^a   Tong, Tan Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Advanced glycosylation end products (ages); Aging; Calorie restriction (cr); Cancer; Drug; SIRT1; TOR

Indexed keywords

EID: 78651285844     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00152     Document Type: Review

References (58)

1. Takaoka M. Resveratrol, a new phenolic compound from Veratrum grandiflorum. J Chemical Society of Japan, 1939, 60(11): 1090-1100
2. Howitz K T, Bitterman K J, Cohen H Y, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954): 191-196
3. Jarolim S, Millen J, Heeren G, et al. A novel assay for replicative lifespan in Saccharomyces cerevisiae. FEMS Yeast Res, 2004, 5(2): 169-177
4. Wood J G, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 2004, 430(7000): 686-689
5. Kaeberlein M, Mcdonagh T, Heltweg B, et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem, 2005, 280(17): 17038-17045
6. Bass T M, Weinkove D, Houthoofd K, et al. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev, 2007, 128(10): 546-552
7. Baur J A, Pearson K J, Price N L, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444(7117): 337-342
8. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127(6): 1109-1122
9. Barger J L, Kayo T, Vann J M, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One, 2008, 3(6): e2264
10. Lopez-Burillo S, Tan D X, Mayo J C, et al. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J Pineal Res, 2003, 34(4): 269-277
11. Higdon J V, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr, 2003, 43(1): 89-143
12. Brown M K, Evans J L, Luo Y. Beneficial effects of natural antioxidants EGCG and alpha-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacol Biochem Behav, 2006, 85(3): 620-628
13. Rezai-Zadeh K, Shytle D, Sun N, et al. Green tea epigallocatechin3- gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci, 2005, 25(38): 8807-8814
14. Zhang L, Jie G, Zhang J, et al. Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress. Free Radic Biol Med, 2009, 46(3): 414-421
15. Kim J, Zhang X, Rieger-Christ K M, el al. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem, 2006, 281 (16): 10865-10875
16. Rieger-Christ K M, Hanley R, Lodowsky C, et al. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. J Cell Biochem, 2007, 102(2): 377-388
17. Hipkiss A R. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol, 2006, 41(5): 464-473
18. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract, 2005, 67(1): 3-21
19. Hipkiss A R. On the anti-aging activities of aminoguanidine and N-t-butylhydroxylamine. Mech Ageing Dev, 2001, 122(2): 169-171
20. Hipkiss A R, Brownson C. A possible new role for the anti-ageing peptide carnosine. Cell Mol Life Sci, 2000, 57(5): 747-753
21. Hipkiss A R. Glycation, ageing and carnosine: are carnivorous diets beneficial?. Mech Ageing Dev, 2005, 126(10): 1034-1039
22. Fujisawa H, Nishikawa T, Zhu B H, et al. Aminoguanidine supplementation delays the onset of senescence in vitro in dermal fibroblast-like cells from senescence-accelerated mice. J Gerontol A Biol Sci Med Sci, 1999, 54(7): B276-B282
23. Chang K C, Hsu K L, Peng Y I, et al. Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis. Br J Pharmacol, 2003, 140(1): 107-114
24. Chang K C, Hsu K L, Chou T F, et al. Aminoguanidine prevents age-related deterioration in left ventricular-arterial coupling in Fisher 344 rats. Br J Pharmacol, 2004, 142(7): 1099-1104
25. Moreau R, Nguyen B T, Doneanu C E, et al. Reversal by aminoguanidine of the age-related increase in glycoxidation and lipoxidation in the cardiovascular system of Fischer 344 rats. Biochem Pharmacol, 2005, 69(1): 29-40
26. Stoppa G R, Cesquini M, Roman E A, et al. Aminoguanidine prevented impairment of blood antioxidant system in insulindependent diabetic rats. Life Sci, 2006, 78(12): 1352-1361
27. Nilsson B O. Biological effects of aminoguanidine: an update. Inflamm Res, 1999, 48(10): 509-515
28. Bauer K, Schulz M. Biosynthesis of carnosine and related peptides by skeletal muscle cells in primary culture. Eur J Biochem, 1994, 219(1-2): 43-47
29. McFarland G A, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res, 1994, 212(2): 167-175
30. McFarland G A, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Gerontol, 1999, 34(1): 35-45
31. Holliday R, Mcfarland G A. A role for carnosine in cellular maintenance. Biochemistry (Mose), 2000, 65(7): 843-848
32. Shao L, Li Q H, Tan Z. L-carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts. Biochem Biophys Res Commun, 2004, 324(2): 931-936
33. Campisi J, Kim S H, Lim C S, et al. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol, 2001, 36(10): 1619-1637
34. Allsopp R C, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA, 1992, 89(21): 10114-10118
35. Allsopp R C, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res, 1995, 220(1): 194-200
36. Yuneva A O, Kramarenko G G, Vetreshchak T V, et al. Effect of carnosine on Drosophila melanogaster lifespan. Bull Exp Biol Med, 2002, 133(6): 559-561
37. Brownson C, Hipkiss A R. Carnosine reacts with a glycated protein. Free Radic Biol Med, 2000, 28(10): 1564-1570
38. Petrascheck M, Ye X, Buck L B. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature, 2007, 450(7169): 553-556
39. Zarse K, Ristow M. Antidepressants of the serotonin-antagonist type increase body fat and decrease lifespan of adult Caenorhabditis elegans. PLoS One, 2008, 3(12): e4062
40. Petrascheck M, Ye X, Buck L B. A high-throughput screen for chemicals that increase the lifespan of Caenorhabditis elegans. Ann N Y Acad Sci, 2009, 1170: 698-701
41. Evason K, Collins J J, Huang C, et al. Valproic acid extends Caenorhabditis elegans lifespan. Aging Cell, 2008, 7(3): 305-317
42. Vetencourt J F M, Sale A, Viegi A, et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science, 2008, 320(5874): 385-388
43. Bjornsti M A, Houghton P J. The TOR pathway: a target for cancer therapy. Nat Rev Cancer, 2004, 4(5): 335-348
44. Blagosklonny M V. Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY). 2009, 1(3): 281-288
45. Harrison D E, Strong R, Sharp Z D, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 2009, 460(7253): 392-395
46. Zhuo L, Cai G, Liu F, et al. Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging. Mech Ageing Dev, 2009, 130(10): 700-708
47. Onken B, Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 2010, 5(1): e8758
48. Anisimov V N, Berstein L M, Egormin P A, et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol, 2005, 40(8-9): 685-693
49. Anisimov V N, Egormin P A, Piskunova T S, et al. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle, 2010, 9(1): 188-197
50. Anisimov V N, Berstein L M, Egormin P A, et al. Metformin slows down aging and extends life span of female SHR mice. Cell Cycle, 2008, 7(17): 2769-2773
51. Pearce E L, Walsh M C, Cejas P J, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature, 2009, 460(7251): 103-107
52. Araki K, Turner A P, Shaffer V O, et al. mTOR regulates memory CD8 T-cell differentiation. Nature, 2009, 460(7251): 108-112
53. Prlic M, Bevan M J. Immunology: a metabolic switch to memory. Nature, 2009, 460(7251): 41-42
54. Ingram D K, Zhu M, Mamczarz J, et al. Calorie restriction mimetics: an emerging research field. Aging Cell, 2006, 5 (2): 97-108
55. Spindler S R. Use of microarray biomarkers to identify longevity therapeutics. Aging Cell, 2006, 5(1): 39-50
56. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature, 2000, 408(6809): 255-262
57. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol, 2000, 35(3): 317-329
58. Collado M, Blasco M A, Serrano M. Cellular senescence in cancer and aging. Cell, 2007, 130(2): 223-233